ATAI News and Press, ATAI Life Sciences N.V. From 01/26/23

Lawmakers in three separate states have introduced legislation to legalize psychedelics in 2023, increasing the number of states in the Unite States that are considering psychedelic reform this session to more than a dozen. Recent research has revealed that psychedelic drugs such as psilocybi...

Palm Beach, FL – January 26, 2023 – FinancialNewsMedia.com News Commentary – Even during the recent global supply chain problems, certain markets have continued to show growth. The psychedelic drugs markets is one of these continually expanding markets. Psychedeli...

Summary Numinus reported solid improvements in operational metrics for its Wellness Clinic operations in 1Q23, including a 14% increase in client appointments relative to the prior quarter. Numinus is generating substantial revenue streams, but cash burn is a serious challenge for the c...

Legislators in various states in the country are working to advance psychedelic reform during the 2023 session. The proposals introduced range from the decriminalization of natural plants and fungi to the legalization of psilocybin for therapeutic use. Below is an overview of some of the me...

--News Direct-- When psychedelics were first studied more than 50 years ago, researchers discovered that they were useful in assisting people in exploring a greater sense of self. After a half-century hiatus, scientists are once again investigating psychedelics and other mind-altering substan...

Summary Stephen Tobin on investing in psychedelic stocks while they're still pre-revenue. Will first-movers get the advantage? Importance of patents and cash in the industry. Why he's a big believer in Compass and Atai and not as much in Cybin or MindMed. What will move share pr...

Various indigenous cultures found, used, and promoted plant-based psychedelics for human wellness and spiritual development for thousands of years, in almost every place where humans lived on the planet. Psilocybin is a sacred herb grown and consumed in many places around the world, including...

New research has found that the intensity of a psilocybin trip doesn’t depend on an individual’s body mass index (BMI). BMI is a measure of body fat based on height and weight that applies to adults. Psilocybin is the primary psychoactive compound found in hallucinogenic mushroo...

GRX-917 (deuterated etifoxine) was well-tolerated with no dose-limiting toxicities and only mild adverse effects comparable to that of placebo in both single and multiple ascending doses, as previously announced as preliminary results during atai’s R&D day. Final results demonstrat...

Summary What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management. He shares what investors should focus on in the sector and the pros and cons of owning his top 5 psychedelic stocks. ...